Safety of longer linezolid regimen in children with drug-resistant tuberculosis and extensive tuberculosis in Southwest China
Authors:
Open Access
- 1 June 2020
- journal article
- research article
- Published by Elsevier in Journal of Global Antimicrobial Resistance
- Vol. 21, 375-379
Abstract
No abstract availableKeywords
Funding Information
- evel Medical Reserved Personnel Training Project of Chongqing
- ing Health Commission (2018ZDXM041].)
This publication has 17 references indexed in Scilit:
- Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in ChinaEuropean Respiratory Journal, 2014
- Linezolid for Treatment of Chronic Extensively Drug-Resistant TuberculosisNew England Journal of Medicine, 2012
- Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysisEuropean Respiratory Journal, 2012
- Drug-Induced liver injury with hypersensitivity features has a better outcome: A single-center experience of 39 children and adolescentsHepatology, 2011
- Fatal lactic acidosis after prolonged linezolid exposure for treatment of multidrug-resistant tuberculosisEuropean Journal of Internal Medicine, 2009
- The Site of Action of Oxazolidinone Antibiotics in Living Bacteria and in Human MitochondriaMolecular Cell, 2007
- Inhibition of Mammalian Mitochondrial Protein Synthesis by OxazolidinonesAntimicrobial Agents and Chemotherapy, 2006
- Linezolid-Induced Inhibition of Mitochondrial Protein SynthesisClinical Infectious Diseases, 2006
- Mitochondrial Toxicity Associated with LinezolidNew England Journal of Medicine, 2005
- 1 H Nuclear Magnetic Resonance Study of Oxazolidinone Binding to Bacterial RibosomesAntimicrobial Agents and Chemotherapy, 2002